Clinical trial
Pilot Study of Denileukin Diftitox Plus High-Dose IL-2 for Patients With…
NCT00278369 · Northwestern University, Other · Completed
Key facts
| NCT number | NCT00278369 |
|---|---|
| Title | Pilot Study of Denileukin Diftitox Plus High-Dose IL-2 for Patients With Metastatic Renal Cancer |
| Official title | A Pilot Study of Denileukin Diftitox in Combination With High-Dose IL-2 for Patients With Metastatic Renal Cell Carcinoma |
| Lead sponsor | Northwestern University, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Early Phase 1 |
| Study type | Interventional |
| Conditions | Kidney Cancer |
| Intervention type | Biological |
| Interventions | aldesleukin, denileukin diftitox |
| Enrollment | 20 |
| Start date | Apr 1, 2005 |
| Primary completion | Jun 1, 2009 |
| Completion | Sep 1, 2010 |
| First posted | Jan 18, 2006 |
| Last update posted | May 22, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: